Literature DB >> 19705481

Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I.

Marta Margeta1, Anne M Connolly, Thomas L Winder, Alan Pestronk, Steven A Moore.   

Abstract

Limb-girdle muscular dystrophy type 2I (LGMD-2I) is caused by mutations in the fukutin-related protein gene (FKRP) that lead to abnormal glycosylation of alpha-dystroglycan in skeletal muscle. Heart involvement in LGMD-2I is common, but little is known about a underlying cardiac pathology. Herein we describe two patients with LGMD-2I (homozygous FKRP mutation c.826C>A, p.Leu276Ile) who developed severe congestive heart failure that required cardiac transplantation. The dystrophic pathology and impairment of alpha-dystroglycan glycosylation were severe in the heart but mild in skeletal muscle, underscoring the lack of correlation between cardiac and skeletal muscle involvement in some LGMD-2I patients.

Entities:  

Mesh:

Year:  2009        PMID: 19705481      PMCID: PMC2862182          DOI: 10.1002/mus.21432

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  15 in total

1.  High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark.

Authors:  Marie-Louise Sveen; Marianne Schwartz; John Vissing
Journal:  Ann Neurol       Date:  2006-05       Impact factor: 10.422

2.  Dilated cardiomyopathy may be an early sign of the C826A Fukutin-related protein mutation.

Authors:  T Müller; M Krasnianski; R Witthaut; M Deschauer; S Zierz
Journal:  Neuromuscul Disord       Date:  2005-05       Impact factor: 4.296

3.  Cardiac involvement in limb-girdle muscular dystrophy 2I : conventional cardiac diagnostic and cardiovascular magnetic resonance.

Authors:  C Gaul; M Deschauer; C Tempelmann; S Vielhaber; H U Klein; H J Heinze; S Zierz; F Grothues
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

4.  Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I.

Authors:  Maja Poppe; John Bourke; Michelle Eagle; Patrick Frosk; Klaus Wrogemann; Cheryl Greenberg; Francesco Muntoni; Thomas Voit; Volker Straub; David Hilton-Jones; Cheerag Shirodaria; Kate Bushby
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

5.  Phenotypic spectrum associated with mutations in the fukutin-related protein gene.

Authors:  Eugenio Mercuri; Martin Brockington; Volker Straub; Susana Quijano-Roy; Yeliz Yuva; Ralf Herrmann; Susan C Brown; Silvia Torelli; Victor Dubowitz; Derek J Blake; Norma B Romero; Brigitte Estournet; Caroline A Sewry; Pascale Guicheney; Thomas Voit; Francesco Muntoni
Journal:  Ann Neurol       Date:  2003-04       Impact factor: 10.422

6.  Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.

Authors:  Daniel E Michele; Rita Barresi; Motoi Kanagawa; Fumiaki Saito; Ronald D Cohn; Jakob S Satz; James Dollar; Ichizo Nishino; Richard I Kelley; Hannu Somer; Volker Straub; Katherine D Mathews; Steven A Moore; Kevin P Campbell
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

7.  Heart transplantation in a child with LGMD2I presenting as isolated dilated cardiomyopathy.

Authors:  Adele D'Amico; Stefania Petrini; Francesco Parisi; Alessandra Tessa; Paola Francalanci; Giorgia Grutter; Filippo M Santorelli; Enrico Bertini
Journal:  Neuromuscul Disord       Date:  2007-12-03       Impact factor: 4.296

8.  Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome.

Authors:  D Beltran-Valero de Bernabé; T Voit; C Longman; A Steinbrecher; V Straub; Y Yuva; R Herrmann; J Sperner; C Korenke; C Diesen; W B Dobyns; H G Brunner; H van Bokhoven; M Brockington; F Muntoni
Journal:  J Med Genet       Date:  2004-05       Impact factor: 6.318

9.  Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study.

Authors:  Karim Wahbi; Christophe Meune; El Hadi Hamouda; Tania Stojkovic; Pascal Laforêt; Henri Marc Bécane; Bruno Eymard; Denis Duboc
Journal:  Neuromuscul Disord       Date:  2008-07-17       Impact factor: 4.296

10.  Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy.

Authors:  Caroline Godfrey; Diana Escolar; Martin Brockington; Emma M Clement; Rachael Mein; Cecilia Jimenez-Mallebrera; Silvia Torelli; Lucy Feng; Susan C Brown; Caroline A Sewry; Mary Rutherford; Yehuda Shapira; Stephen Abbs; Francesco Muntoni
Journal:  Ann Neurol       Date:  2006-11       Impact factor: 10.422

View more
  21 in total

1.  Urologic and gastrointestinal symptoms in the dystroglycanopathies.

Authors:  Cameron D Crockett; Laura A Bertrand; Christopher S Cooper; Riad M Rahhal; Ke Liu; M Bridget Zimmerman; Steven A Moore; Katherine D Mathews
Journal:  Neurology       Date:  2015-01-07       Impact factor: 9.910

Review 2.  Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.

Authors:  Dewayne Townsend
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

3.  AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression.

Authors:  Evelyne Gicquel; Natacha Maizonnier; Steven J Foltz; William J Martin; Nathalie Bourg; Fedor Svinartchouk; Karine Charton; Aaron M Beedle; Isabelle Richard
Journal:  Hum Mol Genet       Date:  2017-05-15       Impact factor: 6.150

4.  Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy.

Authors:  Luca Bello; Paola Melacini; Raffaele Pezzani; Adele D'Amico; Luisa Piva; Emanuela Leonardi; Annalaura Torella; Gianni Soraru; Arianna Palmieri; Gessica Smaniotto; Bruno F Gavassini; Andrea Vianello; Vincenzo Nigro; Enrico Bertini; Corrado Angelini; Silvio C E Tosatto; Elena Pegoraro
Journal:  Eur J Hum Genet       Date:  2012-05-02       Impact factor: 4.246

Review 5.  Cardiac complications of congenital disorders of glycosylation (CDG): a systematic review of the literature.

Authors:  D Marques-da-Silva; R Francisco; D Webster; V Dos Reis Ferreira; J Jaeken; T Pulinilkunnil
Journal:  J Inherit Metab Dis       Date:  2017-07-19       Impact factor: 4.982

6.  Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functions.

Authors:  Lei Xu; Pei Juan Lu; Chi-Hsien Wang; Elizabeth Keramaris; Chunping Qiao; Bin Xiao; Derek J Blake; Xiao Xiao; Qi Long Lu
Journal:  Mol Ther       Date:  2013-07-02       Impact factor: 11.454

7.  Severe, fatal multisystem manifestations in a patient with dolichol kinase-congenital disorder of glycosylation.

Authors:  Michelle T Lieu; Bobby G Ng; Jeffrey S Rush; Tim Wood; Monica J Basehore; Madhuri Hegde; Richard C Chang; Jose E Abdenur; Hudson H Freeze; Raymond Y Wang
Journal:  Mol Genet Metab       Date:  2013-10-04       Impact factor: 4.797

Review 8.  Fukutin-Related Protein: From Pathology to Treatments.

Authors:  Carolina Ortiz-Cordero; Karim Azzag; Rita C R Perlingeiro
Journal:  Trends Cell Biol       Date:  2020-12-01       Impact factor: 20.808

Review 9.  Importance of evaluating protein glycosylation in pluripotent stem cell-derived cardiomyocytes for research and clinical applications.

Authors:  Maia I Kelly; Mustafa Albahrani; Chase Castro; Ellen Poon; Bin Yan; Jack Littrell; Matthew Waas; Kenneth R Boheler; Rebekah L Gundry
Journal:  Pflugers Arch       Date:  2021-04-08       Impact factor: 3.657

10.  Illness-associated muscle weakness in dystroglycanopathies.

Authors:  Courtney R Carlson; Steven D McGaughey; Jamie M Eskuri; Carrie M Stephan; M Bridget Zimmerman; Katherine D Mathews
Journal:  Neurology       Date:  2017-11-03       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.